To beat China in the lab, America’s edge is trust not speed

The United States is concerned about losing ground to China in clinical research but argues that prioritizing trial reform as a race may overlook the goal of creating a faster, safer, and more trusted model for medicine development. The Food and Drug Administration (FDA) is highlighted as a key player in this context.